DARIFENACIN
Substance profile for UNII APG9819VLM, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- APG9819VLM
- Preferred term
- DARIFENACIN
- Registry number
- 133099-04-4
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C28H30N2O2
Chemical And Database Identifiers#
- InChIKey
- HXGBXQDTNZMWGS-RUZDIDTESA-N
- SMILES
- NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C4=CC=CC=C4)C5=CC=CC=C5
- RxCUI
- 136198
- PubChem
- 444031
- NCIt
- C65363
- INN ID
- 7153
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| PubChem Compound | 444031 | https://pubchem.ncbi.nlm.nih.gov/compound/444031 |
| PubChem InChIKey Search | HXGBXQDTNZMWGS-RUZDIDTESA-N | https://pubchem.ncbi.nlm.nih.gov/#query=HXGBXQDTNZMWGS-RUZDIDTESA-N |
| RxNorm | 136198 | https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=136198 |
| NCI Thesaurus | C65363 | https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C65363 |
| FDA Substance Registration System | APG9819VLM | https://precision.fda.gov/uniisearch/srs/unii/APG9819VLM |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DARIFENACIN | ACTIVE MOIETY | APG9819VLM | ENABLEX ® (darifenacin) Extended -release tablets Rx only Prescribing Information | 1 | |
| DARIFENACIN | ACTIVE INGREDIENT | APG9819VLM | ENABLEX ® (darifenacin) Extended -release tablets Rx only Prescribing Information | 1 | |
| DARIFENACIN | ACTIVE MOIETY | APG9819VLM | ENABLEX (DARIFENACIN) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3613 | |
| DARIFENACIN | ACTIVE INGREDIENT | APG9819VLM | ENABLEX (DARIFENACIN) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3613 | |
| DARIFENACIN | ACTIVE MOIETY | APG9819VLM | ENABLEX (DARIFENACIN) TABLET, EXTENDED RELEASE [WARNER CHILCOTT (US), LLC] | 8 |